1
|
Uchida K, Masamune A, Shimosegawa T and
Okazaki K: Prevalence of IgG4-related disease in Japan based on
nationwide survey in 2009. Int J Rheumatol.
2012(358371)2012.PubMed/NCBI View Article : Google Scholar
|
2
|
Sato T, Minegishi K, Okabe N, Osuga F,
Sudo K, Sogabe M, Endo S and Tsubochi H: Bronchial obstruction in
immunoglobulin G4-related disease. Ann Thorac Surg Short Rep,
2024.
|
3
|
Sarles H, Sarles JC, Muratore R and Guien
C: Chronic inflammatory sclerosis of the pancreas-an autonomous
pancreatic disease? Am J Dig Dis. 6:688–698. 1961.PubMed/NCBI View Article : Google Scholar
|
4
|
Kamisawa T, Funata N, Hayashi Y, Eishi Y,
Koike M, Tsuruta K, Okamoto A, Egawa N and Nakajima H: A new
clinicopathological entity of IgG4-related autoimmune disease. J
Gastroenterol. 38:982–984. 2003.PubMed/NCBI View Article : Google Scholar
|
5
|
Wallace ZS, Naden RP, Chari S, Choi H,
Della-Torre E, Dicaire JF, Hart PA, Inoue D, Kawano M, Khosroshahi
A, et al: The 2019 American college of rheumatology/European league
against rheumatism classification criteria for IgG4-related
disease. Arthritis Rheumatol. 72:7–19. 2020.PubMed/NCBI View Article : Google Scholar
|
6
|
Stone JH, Khosroshahi A, Deshpande V, Chan
JKC, Heathcote JG, Aalberse R, Azumi A, Bloch DB, Brugge WR,
Carruthers MN, et al: Recommendations for the nomenclature of
IgG4-related disease and its individual organ system
manifestations. Arthritis Rheum. 64:3061–3067. 2012.PubMed/NCBI View Article : Google Scholar
|
7
|
Wang X, Wan J, Zhao L, Da J, Cao B and
Zhai Z: IgG4-related disease with tracheobronchial miliary nodules
and asthma: A case report and review of the literature. BMC Pulm
Med. 19(191)2019.PubMed/NCBI View Article : Google Scholar
|
8
|
Umehara H, Okazaki K, Kawa S, Takahashi H,
Goto H, Matsui S, Ishizaka N, Akamizu T, Sato Y, Kawano M, et al:
The 2020 revised comprehensive diagnostic (RCD) criteria for
IgG4-RD. Mod Rheumatol. 31:529–533. 2021.PubMed/NCBI View Article : Google Scholar
|
9
|
Li PH, Ko K, Ho CT, Lau LL, Tsang RK,
Cheung T, Leung WK and Lau CS: Immunoglobulin G4-related disease in
Hong Kong: Clinical features, treatment practices, and its
association with multisystem disease. Hong Kong Med J. 23:446–453.
2017.PubMed/NCBI View Article : Google Scholar
|
10
|
Matsui S: IgG4-related respiratory
disease. Mod Rheumatol. 29:251–256. 2019.PubMed/NCBI View Article : Google Scholar
|
11
|
Matsui S, Hebisawa A, Sakai F, Yamamoto H,
Terasaki Y, Kurihara Y, Waseda Y, Kawamura T, Miyashita T, Inoue H,
et al: Immunoglobulin G4-related lung disease: Clinicoradiological
and pathological features. Respirology. 18:480–487. 2013.PubMed/NCBI View Article : Google Scholar
|
12
|
Yamakawa H, Takemura T, Tsumiyama E, Sato
S, Akasaka K, Amano M and Matsushima H: IgG4-related bronchial
gland inflammation proved by transbronchial cryobiopsy. Am J Respir
Crit Care Med. 201:1554–1556. 2020.PubMed/NCBI View Article : Google Scholar
|
13
|
Shrestha B, Sekiguchi H, Colby TV,
Graziano P, Aubry MC, Smyrk TC, Feldman AL, Cornell LD, Ryu JH,
Chari ST, et al: Distinctive pulmonary histopathology with
increased IgG4-positive plasma cells in patients with autoimmune
pancreatitis: report of 6 and 12 cases with similar histopathology.
Am J Surg Pathol. 33:1450–1462. 2009.PubMed/NCBI View Article : Google Scholar
|
14
|
Torii A, Oshima K, Iwakoshi A and Oki M: A
case with multiple nodules and mucosal oedema of the trachea and
both bronchi induced by IgG4-related disease. BMC Pulm Med.
24(115)2024.PubMed/NCBI View Article : Google Scholar
|
15
|
Otani K, Inoue D, Fujikura K, Komori T,
Abe-Suzuki S, Tajiri T, Itoh T and Zen Y: Idiopathic multicentric
Castleman's disease: A clinicopathologic study in comparison with
IgG4-related disease. Oncotarget. 9:6691–6706. 2018.PubMed/NCBI View Article : Google Scholar
|
16
|
Ebbo M, Grados A, Bernit E, Vély F,
Boucraut J, Harlé JR, Daniel L and Schleinitz N: Pathologies
associated with serum IgG4 elevation. Int J Rheumatol. 2012:1–6.
2012.PubMed/NCBI View Article : Google Scholar
|
17
|
Otani K, Inoue D, Itoh T and Zen Y:
Transbronchial lung biopsy for the diagnosis of IgG4-related lung
disease. Histopathology. 73:49–58. 2018.PubMed/NCBI View Article : Google Scholar
|
18
|
Tanaka Y and Stone JH: Perspectives on
current and emerging therapies for immunoglobulin G4-related
disease. Mod Rheumatol. 33:229–236. 2023.PubMed/NCBI View Article : Google Scholar
|
19
|
Ebbo M, Grados A, Samson M, Groh M,
Loundou A, Rigolet A, Terrier B, Guillaud C, Carra-Dallière C,
Renou F, et al: Long-term efficacy and safety of rituximab in
IgG4-related disease: Data from a French nationwide study of
thirty-three patients. PLoS One. 12(e0183844)2017.PubMed/NCBI View Article : Google Scholar
|
20
|
Stone JH, Khosroshahi A, Zhang W, Della
Torre E, Okazaki K, Tanaka Y, Löhr JM, Schleinitz N, Dong L,
Umehara H, et al: Inebilizumab for treatment of IgG4-related
disease. N Engl J Med: Nov 14, 2024 (Epub ahead of print).
|